You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune modulation therapy

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)

Completed
Has Results
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Anaheim, California
  • +20 more
Nov 30, 2022

Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular

Recruiting
  • Aggressive B-Cell Non-Hodgkin Lymphoma
  • +19 more
  • CD47 Antagonist ALX148
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Disc Herniation, Cervical Radiculopathy, Cervical Radiculopathy at C5 Nerve Root Trial in Ismailia (Sustained natural apophyseal

Recruiting
  • Disc Herniation
  • +4 more
  • Sustained natural apophyseal glides (SNAGS)
  • +2 more
  • Ismailia, Egypt
    Ismailia medical complex
Mar 27, 2023

HIV Trial in Puerto Rico, United States (Ritonavir, Nelfinavir mesylate, Efavirenz)

Completed
  • HIV Infections
  • Chicago, Illinois
  • +5 more
Oct 28, 2021

Neck Syndrome Trial in Rawalpindi (Neck Stabilization Training Program, Conventional physical therapy)

Completed
  • Neck Syndrome
  • Neck Stabilization Training Program
  • Conventional physical therapy
  • Rawalpindi, Punjab, Pakistan
    Railway General Hospital
Jul 27, 2022

OCD Trial in Oconomowoc (transcranial direct current stimulation, Sham transcranial direct current stimulation)

Not yet recruiting
  • Obsessive-Compulsive Disorder
  • transcranial direct current stimulation
  • Sham transcranial direct current stimulation
  • Oconomowoc, Wisconsin
    Rogers Behavioral Health
Jul 19, 2023

Venous Leg Ulcer Trial in Worldwide (Venous Leg Ulcer Standard of Care with Granulox)

Active, not recruiting
  • Venous Leg Ulcer
  • Venous Leg Ulcer Standard of Care with Granulox
  • Split, Croatia
  • +26 more
Jan 16, 2023

Advanced Solid Tumors Trial in La Jolla, Saint Louis, Seattle (DN1508052-01)

Completed
  • Advanced Solid Tumors
  • La Jolla, California
  • +2 more
Nov 17, 2022

Diffuse Large B-cell Lymphoma Trial in Toulouse (Patient with histologically confirmed diffuse large B-cell lymphoma with a

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Patient with histologically confirmed diffuse large B-cell lymphoma with a planned first line treatment by R-CHOP.
  • Toulouse, France
    Institut Universitaire du Cancer Toulouse - Oncopole
Mar 28, 2022

Malignant Melanoma Trial in Los Angeles, Houston, Uppsala (delolimogene mupadenorepvec, atezolizumab)

Recruiting
  • Malignant Melanoma
  • delolimogene mupadenorepvec
  • atezolizumab
  • Los Angeles, California
  • +2 more
Apr 4, 2022

Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)

Recruiting
  • Glycogen Storage Disease Type IA
  • DTX401
  • +3 more
  • Orange, California
  • +16 more
Jan 13, 2023

Ovarian Cancer Trial (biological, drug, radiation)

Withdrawn
  • Ovarian Cancer
  • Avelumab
  • +17 more
  • (no location specified)
Mar 17, 2021

Cancer Trial in Boston (Abemaciclib)

Recruiting
  • Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Fibromyalgia Trial in Istanbul, Istanbul (Neural Therapy, Kinesio taping)

Completed
  • Fibromyalgia
  • Neural Therapy
  • Kinesio taping
  • Istanbul, Fatıh, Turkey
  • +1 more
Nov 14, 2022

Suicide, Attempted, Suicidal Ideation Trial in Saint-Paul (music therapy)

Suspended
  • Suicide, Attempted
  • Suicidal Ideation
  • music therapy
  • Saint-Paul, Réunion
    Etablissement Public de Santé Mentale de La Réunion
Oct 19, 2022

Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 12, 2023

Cognitive Impairment, Glioma Trial in Amsterdam (repetitive transcranial magnetic stimulation (rTMS), cognitive strategy

Not yet recruiting
  • Cognitive Impairment
  • Glioma
  • repetitive transcranial magnetic stimulation (rTMS)
  • cognitive strategy training
  • Amsterdam, Netherlands
    VU University Medical Centers, location VUmc
Sep 15, 2023

Frailty Trial in Houston (Vertebral Bone Marrow-Mesenchymal Stem Cells (vBM-MSCs))

Not yet recruiting
  • Frailty
  • Mesenchymal Stem Cells (MSCs)
  • Houston, Texas
    Michael E. DeBakey VA Medical Center, Houston, TX
Nov 16, 2022

PTSD, Opioid Use Disorder Trial in Cape Girardeau (Sparrow Ascent tAN, Sparrow Ascent Active Sham)

Not yet recruiting
  • Posttraumatic Stress Disorder
  • Opioid Use Disorder
  • Sparrow Ascent tAN
  • Sparrow Ascent Active Sham
  • Cape Girardeau, Missouri
    Gibson Center for Behavioral Change
Nov 14, 2023

N/A Healthy Individuals Trial (Myofascial Release, Light Touch Contact)

Not yet recruiting
  • N/A Healthy Individuals
  • Myofascial Release
  • Light Touch Contact
  • (no location specified)
Jun 21, 2023

Hypoxic-Ischemic Encephalopathy, Asphyxia, Hypotension Trial in Budapest (Hydrocortisone)

Recruiting
  • Hypoxic-Ischemic Encephalopathy
  • +3 more
  • Budapest, Pest Megye, Hungary
    Semmelweis University Department of Pediatrics (Bókay street Uni
Apr 19, 2023

Parkinson Disease, Depression, Anxiety Trial in San Francisco (Psilocybin therapy)

Recruiting
  • Parkinson Disease
  • +2 more
  • Psilocybin therapy
  • San Francisco, California
    University of California, San Francisco
Oct 25, 2022

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Iptacopan (LNP023))

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Iptacopan (LNP023)
  • Tianjin, Tianjin, China
  • +11 more
Nov 21, 2022

Acute Ischemic Stroke, Reperfusion, Large Vessel Occlusion Trial in Liuzhou, Changsha, Pingxiang (Y-6 sublingual tablets,

Not yet recruiting
  • Acute Ischemic Stroke
  • +2 more
  • Y-6 sublingual tablets
  • Placebo tablets of Y-6 sublingual tablet
  • Liuzhou, Guangxi, China
  • +2 more
Apr 19, 2023

Tuberculosis Trial in Cape Town (GSK3036656, RIFAFOUR e-275)

Completed
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Dec 30, 2021